Organigram agrees to acquire Aurora Cannabis for CAD 7.80 per share

By Public Technologies
  • Organigram will acquire Aurora Cannabis for CAD 7.80 per share, valuing the transaction at approximately CAD 561 million on a fully diluted basis.
  • The price represents a 93% premium to the August 10, 2026 closing price and 21% above Curaleaf's competing bid.
  • Shareholders can elect cash, Organigram shares or a combination, subject to proration.
  • The combination targets more than CAD 50 million in synergies across its Canadian and international operations.
  • Completion is expected in January 2027, subject to shareholder, regulatory and court approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611030916BIZWIRE_USPR_____20261103_BW746636) on November 03, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk